(A) Carbohydrate Metabolism Glycogen Storage Disorders Deficiency
Type I- Von gierke’s G 6 Phosphate
Type II- Pompe’s Alpha glucosidase
Type III Cori or Forbes Debranching enzyme
Type IV Branching enzyme
Type V- Mcardle’s Muscle phosphorylase
Type VI -Her’s Hepatic phosphorylase
(B) Lipid Metabolism Disease Deficiency
Fabry’s Alpha galactoside- A(Ceramide trihexoside accumulates)
Niemann- Pick’s Sphingomyelinase (RBC appear as foam cells)
Tay- Sach’s Hexosaminidase A
Sandhoff disease Hexosaminidase A and B
Krabbe Leukodystrophy Galacto Cerebrosidase
Metachromatic Leukodystrophy Arylsulfatase A
Gaucher disease Gluco Cerebrosidase
Tangier Disease Lipid Metabolism Disturbed (Low Alpha lipoprotein)
A Medicare analysis looking at 30-day mortality between hospitals offering PCI and those that don't hints that policy-makers looking to regionalize AMI care need to take into account what works and what doesn't at a local level. Heartwire
A new IVUS study has found that although the metabolic syndrome is associated with accelerated plaque progression, this can be attributed to its individual component risk factors rather than the syndrome itself. Heartwire
Can routine blood count variables be predicators of mortality from coronary heart disease? This long-term study examines the evidence. International Journal of Epidemiology